EN | UA
EN | UA

Help Support

Back

Efficacy of Ciprofloxacin-loaded injectable platelet-rich fibrin in periodontal disease

Periodontitis Periodontitis
Periodontitis Periodontitis

Injectable platelet-rich fibrin (i-PRF), an autologous fibrin matrix, can be used as a vehicle to deliver drugs like Ciprofloxacin locally to periodontal sites. This assessed the effectiveness of Ciprofloxacin-loaded i-PRF (Cip-i-PRF) as an adjunct to scaling and root planing (SRP) in patients (age group of 30‒60 years) diagnosed with Stage II Grade B periodontitis.

See All

Key take away

Injectable platelet-rich fibrin is a promising local drug delivery vehicle for Ciprofloxacin, enhancing clinical outcomes in periodontal therapy when combined with scaling and root planing.

Background

Injectable platelet-rich fibrin (i-PRF), an autologous fibrin matrix, can be used as a vehicle to deliver drugs like Ciprofloxacin locally to periodontal sites. This assessed the effectiveness of Ciprofloxacin-loaded i-PRF (Cip-i-PRF) as an adjunct to scaling and root planing (SRP) in patients (age group of 30‒60 years) diagnosed with Stage II Grade B periodontitis.

Method

In this randomized controlled parallel design trial, 79 periodontal pocket sites were randomized into three groups:

  • Group 1 (n=25): SRP + i-PRF + Cip
  • Group 2 (n=25): SRP + i-PRF
  • Group 3 (n=25): SRP alone

Clinical parameters (probing depth, clinical attachment level, gingival index, plaque index) and microbial levels of Aggregatibacter actinomycetemcomitans were assessed at baseline, 6 weeks, and 12 weeks.

Result

All treatment groups showed significant improvements in clinical and microbial outcomes. Group 1 exhibited the greatest reduction in probing depth and gingival index, along with the highest clinical attachment level gain and a significant reduction in A. actinomycetemcomitans levels at 12 weeks. Group 2 showed moderate improvements, while Group 3 had the least favorable outcomes.

Conclusion

Thus, i-PRF can be considered a potential local drug delivery vehicle for Ciprofloxacin in non-surgical periodontal pocket therapy. It offered enhanced clinical and microbial improvements when paired with SRP.

Source:

Journal of Advanced Periodontology & Implant Dentistry

Article:

Efficacy of injectable platelet-rich fibrin (i-PRF) as a novel vehicle for local drug delivery in non-surgical periodontal pocket therapy: A randomized controlled clinical trial

Authors:

Murugan Thamaraiselvan et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: